REYKJAVIK, ICELAND, March 5, 2012 - A global leader in non-invasive orthopaedics, Össur has been named among the “Most Innovative Companies in the World,” according to the annual ranking by Fast Company magazine, which salutes “the businesses that matter most, the ones whose innovations are having an impact across their industries and our culture.”
Össur, which was ranked #7 among all healthcare companies globally, develops advanced orthopedic and prosthetic technologies to enable people to enjoy lives without limitations. The Company’s offerings include the Flex-Foot Cheetah carbon fiber running prostheses used by "The Blade Runner," renowned double-amputee sprinter Oscar Pistorius, as well as the world’s first Bionic prosthetic devices for amputees.
A global market leader, Össur has continually invested a generous portion of its revenues to fuel research and development, with an estimated 100 engineers, scientists, and other R&D professionals working at four dedicated facilities around the world to refine existing technologies and develop new prosthetic and orthopaedic breakthroughs. The Company’s IP portfolio currently consists of more than 750 registered patents and designs, as well as countless design awards and accolades, including the rare distinction of designation as a global “Technology Pioneer” by the World Economic Forum.
“We appreciate Fast Company’s recognition of Össur’s contributions to mobility-enabling technologies to date, and remain committed to continually innovating on behalf of people worldwide,” said Jon Sigurdsson, Company president and CEO.
Össur (NASDAQ OMX: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people’s mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapy, including the Flex-Foot Cheetah carbon fiber running prostheses used by "The Blade Runner," renowned double-amputee sprinter Oscar Pistorius. A recognized “Technology Pioneer”, Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur’s educational programs and business solutions. Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. www.ossur.com